AU2021700A - Methods of using temozolomide in the treatment of cancers - Google Patents

Methods of using temozolomide in the treatment of cancers

Info

Publication number
AU2021700A
AU2021700A AU20217/00A AU2021700A AU2021700A AU 2021700 A AU2021700 A AU 2021700A AU 20217/00 A AU20217/00 A AU 20217/00A AU 2021700 A AU2021700 A AU 2021700A AU 2021700 A AU2021700 A AU 2021700A
Authority
AU
Australia
Prior art keywords
temozolomide
cancers
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20217/00A
Inventor
Henry S. Friedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2021700A publication Critical patent/AU2021700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU20217/00A 1998-12-07 1999-12-02 Methods of using temozolomide in the treatment of cancers Abandoned AU2021700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20692898A 1998-12-07 1998-12-07
US09206928 1998-12-07
PCT/US1999/026033 WO2000033823A2 (en) 1998-12-07 1999-12-02 Methods of using temozolomide in the treatment of cancers

Publications (1)

Publication Number Publication Date
AU2021700A true AU2021700A (en) 2000-06-26

Family

ID=22768557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20217/00A Abandoned AU2021700A (en) 1998-12-07 1999-12-02 Methods of using temozolomide in the treatment of cancers

Country Status (3)

Country Link
AU (1) AU2021700A (en)
PE (1) PE20001320A1 (en)
WO (1) WO2000033823A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113058035B (en) * 2021-03-22 2022-11-04 天津市环湖医院 New sonodynamic application of temozolomide and active product MTIC thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015615A1 (en) * 1993-01-14 1994-07-21 Cancer Research Campaign Technology, Ltd. Potentiation of temozolomide in human tumour cells
CA2184545A1 (en) * 1996-07-31 1998-02-01 Pascale Reidenberg Cancer treatment with temozolomide

Also Published As

Publication number Publication date
WO2000033823A3 (en) 2000-10-19
WO2000033823A2 (en) 2000-06-15
PE20001320A1 (en) 2000-12-06

Similar Documents

Publication Publication Date Title
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
GB9824436D0 (en) Methods of treatment
EP0926955A4 (en) Conjugates useful in the treatment of prostate cancer
IL129356A0 (en) Conjugates useful in the treatment of prostate cancer
AU715620C (en) Therapeutic methods and uses
AU5056099A (en) Compounds for use in the treatment of inflammation
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU2566201A (en) Compounds and methods for the treatment of pain
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AU2021700A (en) Methods of using temozolomide in the treatment of cancers
GB9819999D0 (en) Treatment of cancer
AU5097099A (en) Methods and compositions for cancer treatment
AU2390700A (en) Polypeptidic compositions and methods for the treatment of tumors
AU2420201A (en) Compounds and methods for the treatment of pain
AU1592901A (en) Oncolytic combinations for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase